List of Studies ( Metabolite:TG 18:1_20:2_24:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004118 | AN006828 | Lipidomics on Hep3B Cells Overexpressing CGI-158 and PNPLA2 | Cultured cells | Human | Liver disease; Cancer | Amgen | LC-MS |
| ST003988 | AN006569 | Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active | Cultured cells | Human | Cancer | CNRS | LC-MS |
| ST003757 | AN006168 | Untargeted lipidomics of gemcitabine-resistant PDAC cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003341 | AN005475 | Untargeted Lipidomic Profiling of Canine Cancer Cell Lines | Cultured cells | Dog | Cancer | Kojin Therapeutics, Inc. | LC-MS |
| ST001059 | AN001733 | Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South Africa (part-II) | Adipose tissue | Mozambique tilapia | Inflammation | South East Center for Integrated Metabolomics | LC-MS |
